On Thursday night, Food and Drug Administration (FDA) USA decided to approve Moderna Inc’s coronavirus vaccine on an emergency basis, the Financial Times reported, citing people close to the process.
According to Commissioner Stephen Hahn, FDA informed Moderna that it would promptly work towards the finalization and issuance of emergency use authorization for its Covid-19 vaccine candidate.
FDA said it informed Moderna that it would rapidly work towards the finalization and issuance of emergency use authorization for its Covid-19 vaccine candidate.
An external advisers’ panel to FDA profusely recommended emergency use of Moderna vaccine candidate, as a second option for protecting against Covid-19 for the nation.
